Acetylcholine Release Inhibitors

"Acetylcholine Release Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Compounds that block release of the neurotransmitter ACETYLCHOLINE.

Descriptor ID	D065087
MeSH Number(s)	D27.505.519.562.061 D27.505.519.625.120.069 D27.505.696.577.120.069
Concept/Terms	Acetylcholine Release Inhibitors Acetylcholine Release Inhibitors Inhibitors, Acetylcholine Release Acetylcholine Release Antagonists Antagonists, Acetylcholine Release Acetylcholine Release Blockers Blockers, Acetylcholine Release Release Blockers, Acetylcholine

Below are MeSH descriptors whose meaning is more general than "Acetylcholine Release Inhibitors".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Membrane Transport Modulators [D27.505.519.562]
Acetylcholine Release Inhibitors [D27.505.519.562.061]
Neurotransmitter Agents [D27.505.519.625]
Cholinergic Agents [D27.505.519.625.120]
Acetylcholine Release Inhibitors [D27.505.519.625.120.069]
Physiological Effects of Drugs [D27.505.696]
Neurotransmitter Agents [D27.505.696.577]
Cholinergic Agents [D27.505.696.577.120]
Acetylcholine Release Inhibitors [D27.505.696.577.120.069]

Below are MeSH descriptors whose meaning is related to "Acetylcholine Release Inhibitors".

Below are MeSH descriptors whose meaning is more specific than "Acetylcholine Release Inhibitors".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Acetylcholine Release Inhibitors" by people in this website by year, and whether "Acetylcholine Release Inhibitors" was a major or minor topic of these publications.

Bar chart showing 12 publications over 5 distinct years, with a maximum of 5 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2015	1	0	1
2016	1	2	3
2017	5	0	5
2018	2	0	2
2019	1	0	1

Below are the most recent publications written about "Acetylcholine Release Inhibitors" by people in Profiles.

Shahi N, Arosemena M, Kwon J, Abai B, Salvatore D, DiMuzio P. Functional Popliteal Artery Entrapment Syndrome: A Review of Diagnosis and Management. Ann Vasc Surg. 2019 Aug; 59:259-267.

View in: PubMed
Loeb LM, Amorim RP, Mazzacoratti MDGN, Scorza FA, Peres MFP. Botulinum toxin A (BT-A) versus low-level laser therapy (LLLT) in chronic migraine treatment: a comparison. Arq Neuropsiquiatr. 2018 10; 76(10):663-667.

View in: PubMed
Lipton RB, Brennan A, Palmer S, Hatswell AJ, Porter JK, Sapra S, Villa G, Shah N, Tepper S, Dodick D. Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective. J Med Econ. 2018 Jul; 21(7):666-675.

View in: PubMed
Gracies JM, Esquenazi A, Brashear A, Banach M, Kocer S, Jech R, Khatkova S, Benetin J, Vecchio M, McAllister P, Ilkowski J, Ochudlo S, Catus F, Grandoulier AS, Vilain C, Picaut P. Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension. Neurology. 2017 Nov 28; 89(22):2245-2253.

View in: PubMed
O'Connell Ferster AP, Sataloff RT, Shewokis PA, Hu A. Socioeconomic Variables of Patients with Spasmodic Dysphonia: A Preliminary Study. J Voice. 2018 Jul; 32(4):479-483.

View in: PubMed
Francisco GE, Bandari DS, Bavikatte G, Jost WH, Adams AM, Largent J, Esquenazi A. Adult Spasticity International Registry Study: methodology and baseline patient, healthcare provider, and caregiver characteristics. J Rehabil Med. 2017 Aug 31; 49(8):659-666.

View in: PubMed
Pham Q, Campbell R, Mattioni J, Sataloff R. Botulinum Toxin Injections Into the Lateral Cricoarytenoid Muscles for Vocal Process Granuloma. J Voice. 2018 May; 32(3):363-366.

View in: PubMed
Blumenfeld AM, Silberstein SD, Dodick DW, Aurora SK, Brin MF, Binder WJ. Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal Outcomes. Headache. 2017 May; 57(5):766-777.

View in: PubMed
Simpson DM, Patel AT, Alfaro A, Ayyoub Z, Charles D, Dashtipour K, Esquenazi A, Graham GD, McGuire JR, Odderson I. OnabotulinumtoxinA Injection for Poststroke Upper-Limb Spasticity: Guidance for Early Injectors From a Delphi Panel Process. PM R. 2017 02; 9(2):136-148.

View in: PubMed
Silberstein SD. The Use of Botulinum Toxin in the Management of Headache Disorders. Semin Neurol. 2016 Feb; 36(1):92-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement